Stay updated on Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no changes to study data or layout beyond the label. This is a cosmetic update and does not affect how users view or interact with the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded an on-page glossary and updated QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), adjusted capitalization for FEAR Act terms, and updated the page revision to v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Locations section now lists multiple Japanese locations (Aichi-ken, Fukuoka, Hiroshima, Hokkaido, Hyōgo, Kanagawa, Mie-ken, Osaka, Saitama, Tokyo) and per-prefecture location subsections were removed; a revision tag shows v3.3.3.SummaryDifference1%

Stay in the know with updates to Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Japanese Atopic Dermatitis Clinical Trial page.